Introduction
Hypothalamic hamartomas (HH) are congenital, non-neoplastic tumor-like masses containing normal-appearing mature cells.
1,2 HH presentation may include endocrine (central precocious puberty -CPP) or neurological abnormalities (epilepsy and cognitive impairment). 3, 4 Asymptomatic cases have also been reported. 3, 4 HH are composed of ectopic GnRH neurons or TGFa-producing astroglial cells that lead to premature activation of pulsatile GnRH release and consequent CPP. 5 HH represents the main organic cause of CPP, usually manifesting before age four. [1] [2] [3] [4] Neurological symptoms associated with HH characteristically include gelastic (brief spells of laughter) or dacrystic (crying) seizures, usually presenting in infancy, [1] [2] [3] [4] 6 with later occurrence of different seizures types, including focal and generalized seizures, that may be associated with an epileptic encephalopathy. Developmental delay, loss of acquired developmental milestones and behavioral disturbances frequently accompany this scenario, and are considered a hallmark of HH. 1, 7, 8 Case series in which neurologic features are described may be biased towards more severe neurologic involvement. To our knowledge, no study has Purpose: Hypothalamic hamartoma (HH) is the main structural cause of central precocious puberty (CPP). HH is frequently associated with cognitive impairment and epileptic encephalopathies. Disease severity in case series from neurology services may be biased towards more neurologically impaired patients. Aim: To perform a prospective cognitive evaluation in patients with HH presenting with CPP in an endocrinology outpatient clinic setting. Methods: We evaluated fifteen consecutive patients with CPP due to HH presenting to an endocrinology outpatient clinic. CPP was diagnosed at a median age of 0.7 yr (0.4-7 yr). Mean age at neurologic evaluation was 13.9 yrs. Eight patients (53.3%) were male. Epileptic seizures occurred in 5/15 (33%) patients. Two patients presented a single unprovoked seizure (SUS). Three patients were diagnosed with epilepsy. Cognitive evaluation, using age-appropriate Wechsler Intelligence Scale, was performed in 11 patients.
Results: All patients without epilepsy, including two patients with a history of a SUS, had normal neurologic and cognitive evaluation. Epilepsy and SUS were only seen in patients with sessile HH. Three patients with epilepsy presented cognitive or behavioral findings. Reduced intelligence quotients (IQ), in the borderline range, were noted in both patients with epilepsy who underwent full cognitive evaluation. We found no significant correlation between HH diameter or shape and mean full-scale IQ.
Conclusions:
Patients who presented with isolated CPP without epilepsy displayed normal cognition when evaluated after a mean period of 13 years. Occurrence of epilepsy, seen in a minority of patients, but not of a single seizure, was associated with mild cognitive deficit and behavioral disturbances in this case series. ß 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
systematically evaluated cognition in HH patients presenting with CPP outside a neurology clinic setting. We evaluated cognitive functioning in a series of patients who had presented with CPP due to HH to an Endocrine outpatient tertiary referral center.
Patients and methods
Fifteen consecutive patients (8/15 or 53.3% boys) with CPP due to HH were identified in the Developmental Endocrinology Unit Outpatient Clinic at Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brazil.
Written informed consent was obtained from patients, parents or legal guardians, according to procedures approved by the institutional research ethics committee.
Precocious puberty was diagnosed when secondary sexual features appeared before age eight in girls and age nine in boys, and was classified according to Marshall and Tanner criteria. 9, 10 Hormone pubertal levels were defined as: basal LH greater than 0.6 U/L and/or GnRH-stimulated LH peak greater than 15 U/L for girls and 25 U/L for boys (by radioimmunoassay) or greater than 6.9 U/L for girls and >9.6 U/L for boys (by immunofluorometric assay). 11 Bone age was assessed with the Greulich and Pyle method.
12
All patients underwent at least one brain magnetic resonance imaging (MRI) study, that included pre-and post-gadolinium enhanced sagittal T1-weighted images, as well as coronal T1-and T2-weighted images, with 3-mm slices. 13 HH was diagnosed by the finding of a noncontrast-enhancing mass in the tuber cinereum region, isointense on T1-weighted images and iso-or slightly hyperintense on T2 weighted images (see Fig. 1 ).
Neurological evaluation
Patients underwent a complete neurologic evaluation, probing for early motor and cognitive milestones, current cognitive status, and occurrence of isolated or recurrent epileptic seizures (L.H.M.C., L.K.F., L.R.T.). Seizures were classified as gelastic or dacrystic, focal onset or primary generalized seizures (tonic-clonic, tonic or atonic). A sleep and awake digital EEG after sleep deprivation with standard activation procedures (photic stimulation and hyperventilation) was obtained in all but one patient. Repeat MRI studies were obtained to characterize hamartoma's morphological features (diameter and shape). A neuroradiologist (C.C.L.) classified hamartoma shape as: pedunculated (attached to the tuber cinereum without hypothalamus displacement) or sessile (broad-based hypothalamus attachment). 14 
Cognitive evaluation
Two neuropsychologists (C.C.A., N.B.) from the Neurology Division performed cognitive assessment in two 1-h sessions. Age appropriate Brazilian-Portuguese validated versions of the Wechsler Intelligence Scales were administered, yielding Verbal (VIQ), performance (PIQ), and full-scale intelligence quotients (FSIQ). Wechsler Intelligence Scale for adults (WAIS-III) 16 was used for one patient older than 17 years, Weschler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R) 17 was used for one child under age six years, and the remaining patients, aged 6-16 years, were evaluated with Wechsler Intelligence Scale for children (WISC-III). 15 FSIQ was classified as borderline, low average, average, high average, high and very high. IQ scores were compared between patients with and without epilepsy, and for patients with isolated unprovoked seizures.
Statistical analysis
Data were analyzed with SigmaStat for Windows Version 3.5 (Systat, Inc., 2006), and are presented as median and range for variables with non-Gaussian distribution or mean and standard deviation for normal distribution variables (Kolmogorov-Smirnov test). Median HH diameters were compared with Mann-Whitney test. Pearson's correlation was calculated for HH diameter and IQ. Categorical data were compared with Fisher's exact test and logistic regression analysis. Comparisons of VIQ, PIQ and FSIQ means among CPP patients without epilepsy, with SUS and epilepsy were performed with one-way analysis of variance (ANOVA). Statistical significance was considered at p < 0.05.
Results
Median chronological age (CA) of secondary sexual features presentation in girls was 0.5 yr (0.4-7 yr) and 2.0 yr (0.5-5 yr) in boys. Median CA on initial endocrine evaluation was 2.3 yr (0.9-8.1 Mean BA advancement in relation to CA was 2.3 yr in girls and 1.9 yr in boys. All patients had GnRH-stimulated LH levels in pubertal range and underwent treatment with long-acting GnRH analogs (leuprolide acetate 3.75 mg every 28 days) with adequate pubertal suppression.
Neurological evaluation
All patients underwent neurologic evaluation. Median age at evaluation was 13.9 yr (4-24 yr). Prenatal, birth and perinatal history was unremarkable in all patients, as was early developmental milestones achievement.
Ten of the 15 (66%) patients were considered normal from a neurological and cognitive standpoint ( Table 1 ). These ten patients had adequate school performance, as measured by appropriate grade for age and academic achievement (no failed grades). One patient in this group had a college degree. None of these patients reported behavioral or psychiatric problems. There was no history of isolated seizures or epilepsy in this group. Nine of ten patients underwent an EEG study, which were read as normal.
Five patients presented abnormal findings on neurological evaluation (Table 2) . Two reported a single event suggestive of an unprovoked epileptic seizure.
One patient (patient 11) had a history of an isolated brief afebrile episode of unresponsiveness and staring, without associated motor phenomenae that lasted approximately 1 min, at age 20 months, sugestive of a focal seizure with impairment of consciouness. The patient is currently 17 years old and has no academic or social difficulties. EEG was normal.
Another patient (patient 12), currently six years old, presented an isolated afebrile episode at age nine months, described as a generalized tonic clonic seizure preceded by left leg jerking, suggestive of a focal motor seizure. This event occurred shortly after vaccination and did not recur. The patient has no current neurologic or behavioral difficulties. EEG was normal.
Three patients had epilepsy. One patient (patient 13), currently aged 19, reported typical gelastic seizures since age eight months. These seizures do not impair consciousness, last 15-40 s, and are preceded by peculiar feeling in his head and upper abdomen. The patient reported two previous episodes of generalized tonic-clonic seizures that occurred during sleep, around age 12. Generalized seizures did not recur after introduction of antiseizure medication. Gelastic seizures still occur daily, several times a day, despite treatment with a two antiepileptic drug regimen (carbamazepine and clonazepam). The patient completed the eighth grade, but does not currently attend school or work. He suffers from severe social isolation and rarely leaves his home. EEG shows epileptiform activity in the posterior left cerebral quadrant.
The second patient (patient 14), currently 14 yr, had three generalized tonic-clonic seizures preceded by a vague nonspecific feeling. The patient denied other seizure types, including gelastic seizures. The patient was not on antiepileptic drugs until neurological evaluation, when carbamazepine was introduced. EEG, obtained prior to treatment, was normal. This patient also reported school difficulties. He currently attends the sixth grade, after having failed two grades.
The third patient (patient 15), now 15 yr, had gelastic seizures since age three months and generalized tonic-clonic seizures since age three. EEG shows focal epileptiform activity in the left frontalcentral region.
Cognitive evaluation
Eleven out of the 15 patients underwent cognitive evaluation. Seven patients without seizures (Table 1) had IQ scores ranging from low average to high. The two patients with an isolated epileptic seizure showed average high and very high IQ scores ( Table 2 ). Two of the three patients with epilepsy (Table 2 ) underwent a complete cognitive evaluation. Patient 13 was unable to complete cognitive evaluation due to social phobia. The two patients with epilepsy had borderline IQ scores.
Mean FSIQ score of CPP patients without epilepsy was 106.1 AE 14.1, 121.5 AE 12 for those with SUS, and 78.5 AE 4.9 for those with epilepsy (p = 0.029, ANOVA). Mean PIQ score of CPP patients without epilepsy was 107.7 AE 16.6, 120.5 AE 12 for those with SUS, and 82 AE 11.3 for those with epilepsy (p = 0.09, ANOVA). Mean VIQ score of CPP patients without epilepsy was 104.4 AE 14.1, 119.5 AE 9.2 for those with SUS, and 79.5 AE 2.1 for those with epilepsy (p = 0.037, ANOVA).
Neuroimaging studies
In patients without epilepsy, HH had a median diameter of 10 mm (4-30 mm). Regarding shape, five of ten were classified as pedunculated; the other five had sessile masses ( Table 1) .
HH of the three patients with epilepsy had a median diameter of 13 mm (10-20 mm). All HH in this group were sessile (Table 2) . Median HH diameter did not differ between CPP patients with and without epilepsy (p = 0.39). Although all CPP patients with neurological manifestation had sessile HH, there was no influence of HH shape on epilepsy occurrence (p = 0.1). Patients that presented SUS also had sessile HH. We found no significant correlation between HH diameter and FSIQ (r = À0.07, p = 0.8), as well as no significant differences in mean IQ between CPP patients with pedunculated and sessile HH (p > 0.05).
Discussion
Classical neurologic manifestations of HH are medically refractory epilepsy, formerly referred to as catastrophic epilepsy, associated with severe cognitive impairment, mental retardation, behavioral and psychiatric symptoms. This symptom constellation characterizes an epileptic encephalopathy. These patients may also present CPP. Prevalence of neurologic and endocrine abnormalities may differ in patient populations referred to neurology or endocrine clinics. [1] [2] [3] Contrary to what is habitually observed in the patient population referred to neurology clinics, patients evaluated in endocrine clinics may present less severe neurologic involvement. 8 We report the results of a neurological and cognitive evaluation in a consecutive case series of 15 patients with HH identified in a non-neurologic outpatient clinic. Epileptic seizures frequently occur in association with HH. In our series, epilepsy was seen in only 3/15 (20%) of CPP patients and 2/15 (13%) presented with an isolated unprovoked seizure. Lower epilepsy prevalence in this series is explained by a selection bias related to case ascertainment from a non-neurologic outpatient clinic setting. In a large case series of 277 HH patients, 63% of patients had CPP, 61% had seizures and 27% presented with both CPP and seizures. 18, 19 Gelastic seizures are the hallmark of epilepsy associated with HH and usually manifest in infancy. Invasive depth electrode recordings documented ictal onset of gelastic seizures in the hamartomatous lesion. 18, 19, 22 Different seizure types may also occur in this setting, including focal and generalized seizure. It is unclear if these different seizure types involve propagation of discharges from the deep-seated HH lesion or if these seizures may have an independent cortical origin. 8, 22 Surgical treatment of the hamartoma has been reported to lead to complete seizure resolution, including of non-gelastic seizures. [18] [19] [20] [21] Epilepsy has been associated with sessile HH. 3 Some studies have suggested that HH size may play a role in seizure origin. 3 Two of the three patients with epilepsy first presented gelastic seizures and then presented generalized tonic-clonic seizures. Both these cases maintain persistent seizures despite medical treatment with antiseizure medication. One patient did not present gelastic seizures, and reported occasional generalized tonic-clonic seizures. None of the cases presented an epileptic encephalopathy, which is usually associated with frequent, refractory, drop attacks, accompanied by other seizure types. 20, 21 A bias toward less severe forms of epilepsy in this series is again explained by case selection in a nonneurologic patient universe. Association of epilepsy and variable degrees of cognitive decline is a well-recognized complication of medically refractory epilepsy. 4 The underlying neurobiological processes involved in cognitive deterioration in epileptic encephalopathies, including HHrelated encephalopathies, remain incompletely understood. 4, 20, 21, 23 Previous reports of HH case series have underscored the findings of intact or mildly impaired cognition in patients with adult-onset HH-related epilepsy and also in patients presenting with focal epilepsy syndromes, specially temporal lobe epilepsy. 6, 21, 24 These series included only patients with HH-related epilepsy and cognitive decline was linked with epilepsy severity. 6, 21, 24 Cognitive and neurologic evaluation in our case series disclosed intact cognition and absence of behavioral manifestations in patients without epilepsy. Patients with an isolated unprovoked seizure also did not display cognitive or behavioral abnormalities. These patients, usually not represented in series drawn from neurology or epilepsy clinics represent the benign spectrum of HH. Patients with epilepsy from our cohort presented less severe forms of epilepsy than habitually observed in HH from neurology services. Remote occurrence of SUS in two patients in this series did not influenced cognition. The three patients with epilepsy had significantly lower IQ scores than their counterparts without epilepsy. Two patients presented with less severe forms of refractory epilepsy, and one patient presented with occasional tonic-clonic seizures, that had not been previously treated. Two of the patients with epilepsy displayed cognitive functioning in the borderline IQ range. One patient displayed severe psychiatric symptoms with severe impact in daily activities, but, in this patient, full assessment of cognitive status was hindered by the patient's inability to cooperate due to severe social phobia. Our findings support the notion that HH associated with epilepsy is associated with cognitive impairment, albeit not severe in these cases.
Epilepsy cases in this study did not present with more severe epilepsy or cognitive decline. We have previously reported a case series of seven HH patients identified in the neurology service in the same institution. 21 Only one patient presented with precocious puberty, and four presented with severe forms of epilepsy and cognitive impairment, with IQ scores ranging from mild to profound mental retardation. 21 Those cases are not included in this report. We did not found a significant correlation between HH size and epilepsy occurrence. Mean HH size did not differ between patients with and without neurologic and psychiatric symptoms. HH size appears not to be a determinant factor of the occurrence of psychiatric or neurologic involvement associated with HH. These findings are in contrast with a previous study that demonstrated that small and pedunculated HH are associated with CPP, while large and sessile HH are associated with seizures. 13 All our patients with epilepsy or isolated seizures presented sessile HH, a finding that is concordant with other studies. Cognitive impairment and psychiatric manifestations only occurred in patients with sessile HH. However, sessile HH were also seen in patients without epilepsy, cognitive or psychiatric symptoms, indicating that presence of a sessile HH is necessary but not sufficient to cause neurologic and psychiatric symptoms.
We conclude that HH presents as a spectrum of disorders. While pedunculated HH appear to present with isolated endocrine findings, presentation of patients with sessile HH are distributed within a wide spectrum. Cases presenting with precocious puberty, intact cognition without epilepsy represent the less severe end of the spectrum. These cases may not come to the neurologist's attention. A more severe end of the spectrum is represented by patients with severe epilepsy and cognitive impairment. These patients may not present central precocious puberty. The underlying conditions that determine the clinical presentation in cases of sessile HH remain poorly understood.
